NECTIN4 and in situ carcinoma: In the current study we aimed to systematically analyze the expression pattern of NECTIN4 in urothelial HR NMIBC by making use of cohorts for CIS, HG papillary tumors (with and without a history of low-grade (LG) disease) as well as stroma-invasive carcinomas.